Table 2.
RA secreted molecules | Phenotype in cancer cells | Cancer type | Reference |
---|---|---|---|
ET-1 | Induction of cancer cell growth and stemness through activation of MAPK and AKT | Breast and lung cancer | Kim et al. (35) |
IL-23 | Increase invassiveness by inducing MMP2 | Melanoma | Klein et al. (65) |
HGF/SCF | Induction of proangiogenic cytokines by activating c-Met | Breast cancer | Xing et al. (63). |
BDNF | Induction of cancer cell growth through activation of TrKB-HER2 | Breast cancer | Choy et al. (36) |
CCL7 | Induction of tumor initiating potential in cancer cells | Breast cancer | Wu et al. (62) |
MMP2/MMP9 | Increase invassiveness of cancer cells | Breast cancer | Wang et al. (67) |
miR-19a | Induction of cancer cell growth by targeting PTEN | Breast cancer and melanoma | Zhang et al. (37) |
Hyaluronic acid | Induction of cancer cell growth and stemness through activation of MAPK and AKT | Lung cancer | Stevens et al. (38) |
IFNα/TNFα | Induction of cancer cell growth and chemoresistance by STAT1 and NFκB | Breast and lung cancer | Chen et al. (9) |
PA-Plasmin-FasL | Decrease the viability of non-brain-adapted cancer cells | Breast and lung cancer | Valiente et al. (10) |